51 employees
Aduro BioTech is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies.
2019
$51M
from 4 investors over 4 rounds
Aduro Biotech raised $51M on January 5, 2015
Investors: Franklin Advisors, Jennison Associates LLC, OrbiMed Advisors and Foresite Capital